FDA Device Recalls

Recalls /

#158919

Product

BARD MAX-CORE Disposable Core Biopsy Instrument, Product Codes - MC1410, 14 g x 10 cm; MC1616, 16 g x 16 cm; MC1816, 18 g x 16 cm; MC1820, 18 g x 20 cm; MC1825, 18 g x 25 cm. The core needle biopsy device is intended for use in obtaining biopsies from soft tissues.

FDA product code
KNWInstrument, Biopsy
Device class
Class 2
Medical specialty
Gastroenterology, Urology
510(k) numbers
K133948
Affected lot / code info
Lot Numbers: REBP0019, REBN0342, REBN2123, REBP1199, REBP1419, REBP1807, REBQ0084, REBQ0343, REBQ1012, REBP1420, REBP1809, REBP0869, REBP1266, REBP1267, REBP1421, REBP1422, REBP1810, REBQ0087, REBQ0088, REBQ0347, REBQ0811, REBQ1014, REBP0158, REBQ1904, REBQ1898, REBQ1978, REBR0468, REBQ2296, REBR0474

Why it was recalled

During the review of May 2017 complaint data, a significant increase in MAX-CORE Disposable Core Biopsy Instrument complaints was observed for Failure to Prime, Failure to Fire, Failure to Obtain Sample, and Self-Activation.

Root cause (FDA determination)

Device Design

Action the firm took

BPV sent a customer recall letter on September 22, 2017 to each of the US consignees via FedEx with proof of delivery notification. BPV will also initiate a recall for product outside the US in accordance with regulations of each country in which the product was distributed.

Recalling firm

Firm
Bard Peripheral Vascular Inc
Address
1625 W 3rd St, Bldg 1, Tempe, Arizona 85281-2438

Distribution

Distribution pattern
US, Australia, Canada, Europe, Middle East, Africa, Latin America, Asia Pacific

Timeline

Recall initiated
2017-09-22
Terminated
2018-09-27
Status

Source: openFDA Device Recall endpoint. Recall record ID #158919. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

— recall: BARD MAX-CORE Disposable Core Biopsy Instrument, Product Codes - MC1410, 14 g x 10 cm; MC1616, 16 g · FDA Device Recalls